ECR

iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings

Retrieved on: 
Wednesday, February 28, 2024

“The data presented at ECR demonstrate the real-world ability to improve efficiency and accuracy in mammography breast screening—from reducing workloads without compromising accuracy to potentially reducing interval cancer rates and expediting diagnosis for true positive cases.

Key Points: 
  • “The data presented at ECR demonstrate the real-world ability to improve efficiency and accuracy in mammography breast screening—from reducing workloads without compromising accuracy to potentially reducing interval cancer rates and expediting diagnosis for true positive cases.
  • These findings underscore ProFound AI’s transformative power to improve breast healthcare,” said Dana Brown, president and CEO of iCAD.
  • Sunday, March 3, 9:30 – 11:00 am, RPS2305 – Retrospective Evaluation of Interval Breast Cancer: Can the Number of Interval Carcinomas be Reduced Utilizing AI Diagnostic Software?
  • Lastly, iCAD will highlight expanded cloud platform and subscription licensing plans marking a significant advancement in deployment flexibility.

Clinical Research on Photon-Counting CT Begins with Radboud University Medical Center

Retrieved on: 
Tuesday, February 27, 2024

Otawara, Japan, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Canon Medical Systems Corporation (hereinafter "Canon Medical"; President and CEO: Toshio Takiguchi; headquarters: Otawara, Tochigi, Japan) has completed the second installation of its Canon photon-counting CT (PCCT) system worldwide at Radboud University Medical Center (Chair: Dr. Bertine Lahuis; location: Nijmegen, the Netherlands), and clinical research began in late January.

Key Points: 
  • Otawara, Japan, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Canon Medical Systems Corporation (hereinafter "Canon Medical"; President and CEO: Toshio Takiguchi; headquarters: Otawara, Tochigi, Japan) has completed the second installation of its Canon photon-counting CT (PCCT) system worldwide at Radboud University Medical Center (Chair: Dr. Bertine Lahuis; location: Nijmegen, the Netherlands), and clinical research began in late January.
  • PCCT is expected to be the next generation of X-ray CT
    Radboud University Medical Center is an academic medical center specializing in patient care, scientific research, teaching, and training.
  • The Department of Radiology at Radboud University Medical Center leads one of the best research groups in Europe, working with more than 150 researchers on advanced studies to provide patient care and improve health care.
  • Canon Medical entered into an agreement on joint clinical research with Radboud University Medical Center on November 14, 2023,*1 and clinical research aimed at early practical application of PCCT was started, led by Prof. Mathias Prokop, Chairman of the Department of Radiology at Radboud University Medical Center.

Hologic to Unveil Groundbreaking AI Research at ECR 2024

Retrieved on: 
Tuesday, February 27, 2024

The pioneer behind 3D mammography, Hologic will present new data that showcase how next-generation deep-learning solutions can assist with breast cancer detection and improve workflow for radiologists.

Key Points: 
  • The pioneer behind 3D mammography, Hologic will present new data that showcase how next-generation deep-learning solutions can assist with breast cancer detection and improve workflow for radiologists.
  • “Beyond its impact on our daily practices, these data emphasize the transformative potential AI has to drive improvements across the breast health spectrum.
  • “We’re excited to present groundbreaking research at ECR and to continue our collaboration with Bayer on contrast-enhanced mammography.
  • Hologic’s Genius AI® Detection technology is a cutting-edge solution now commercially available in the U.S., with plans for rollout in Europe, Canada and Asia by the end of 2024.

GE HealthCare Showcases Precision Care with Launch of Elevated LOGIQ Ultrasound System Portfolio at European Congress of Radiology 2024

Retrieved on: 
Wednesday, February 28, 2024

GE HealthCare (Nasdaq: GEHC) today announced its latest innovation in ultrasound with the launch of its next-level LOGIQ ultrasound portfolio—including the new LOGIQ Totus—highlighting the company’s progress in advancing precision care.

Key Points: 
  • GE HealthCare (Nasdaq: GEHC) today announced its latest innovation in ultrasound with the launch of its next-level LOGIQ ultrasound portfolio—including the new LOGIQ Totus—highlighting the company’s progress in advancing precision care.
  • “At GE HealthCare, we’re focused on driving innovation that enables precision care, and the enhanced LOGIQ portfolio allows us to deliver on this promise with products and solutions that help clinicians optimize care with ease and efficiency,” said Jyoti Gera, General Manager, General Imaging and Primary Care, Ultrasound at GE HealthCare.
  • With LOGIQ AppAPI, GE HealthCare can collaborate with third parties on applications that run directly on the LOGIQ system or use real-time streaming of ultrasound data to run side-by-side with the LOGIQ system.
  • GE HealthCare will demonstrate the next-generation LOGIQ portfolio at the European Congress of Radiology (ECR) on February 28 to March 3 in Vienna.

Median Technologies to Participate and Speak at the 2024 European Congress of Radiology (ECR), February 28 – March 3, Vienna, Austria

Retrieved on: 
Monday, February 26, 2024

Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announces today that the Company will be participating and speaking at the premier European radiology conference, the European Congress of Radiology (ECR), being held in Vienna, Austria, February 28 – March 3, 2024.

Key Points: 
  • Median Technologies (FR0011049824, ALMDT, PEA/SME eligible) announces today that the Company will be participating and speaking at the premier European radiology conference, the European Congress of Radiology (ECR), being held in Vienna, Austria, February 28 – March 3, 2024.
  • Philippe Grenier, Thoracic Radiologist and Head of the Artificial Intelligence project, Foch Hospital, Saint Cloud, France and Pr.
  • The European Congress of Radiology (ECR) organized by the European Society of Radiology (ESR) is the premier European event in radiology and the second largest in the world.
  • The congress conveys more than 20,000 with a split of more than 10,000 professional delegates (radiologists, technologists etc.

Carestream to Showcase Innovation at ECR 2024

Retrieved on: 
Tuesday, February 20, 2024

Low-profile design and flexibility mean you can easily capture images wherever you need them most.

Key Points: 
  • Low-profile design and flexibility mean you can easily capture images wherever you need them most.
  • Carestream will also display additional imaging innovations at Expo X2-Booth 220 at ECR.
  • These will include the DRX-Compass X-ray System, DRX-Rise Mobile X-ray System, and DRX-Revolution Mobile X-ray System, as well as our suite of DR Detectors.
  • Schedule an appointment to discuss Carestream’s latest innovations and other medical imaging solutions at ECR 2024.

Radcliffe Group Selects Springer Healthcare for Reprint Sales to Pharmaceutical Industry

Retrieved on: 
Tuesday, March 5, 2024

BOURNE END, England, March 5, 2024 /PRNewswire-PRWeb/ -- Today Radcliffe Group, which brings the latest and best science, information, and knowledge to cardiovascular clinicians around the world, announced it has chosen Springer Healthcare in an exclusive deal to handle its reprints to buyers in the pharmaceutical industry. The deal was facilitated by content licensing specialist MEI Global, LLC (MEIG), a leader in helping publishers create new revenue streams through strategic third-party partnerships.

Key Points: 
  • BOURNE END, England, March 5, 2024 /PRNewswire-PRWeb/ -- Today Radcliffe Group, which brings the latest and best science, information, and knowledge to cardiovascular clinicians around the world, announced it has chosen Springer Healthcare in an exclusive deal to handle its reprints to buyers in the pharmaceutical industry.
  • Jonathan McKenna, Managing Director of Radcliffe Cardiology, says "Radcliffe strives to equip healthcare professionals with the skills and practical insights they need to do their best for patients by bringing the world's cardiovascular knowledge to life.
  • We are excited about partnering with Springer Healthcare and leveraging their established connections in the pharmaceutical market to aide us in that goal."
  • "A number of discussions and negotiations for complementary redistribution deals are also underway, and we're excited to help Radcliffe expand the audience for this powerful medical research."

SmartAlpha Partners with Siemens Healthineers to advance AI-powered Workflow Efficiencies in Ultrasound

Retrieved on: 
Friday, March 1, 2024

VIENNA, March 1, 2024 /PRNewswire/ -- SmartAlpha has announced a partnership with Siemens Healthineers with a signing ceremony at the European Congress of Radiology (ECR).

Key Points: 
  • VIENNA, March 1, 2024 /PRNewswire/ -- SmartAlpha has announced a partnership with Siemens Healthineers with a signing ceremony at the European Congress of Radiology (ECR).
  • SmartAlpha's technology has made significant advances through the development of AI-guidance features for real-time ultrasound scanning.
  • "This collaboration represents a significant milestone in the journey of our AI solutions in ultrasound," stated Utku Kaya, Co-founder and CEO of SmartAlpha.
  • "While ultrasound manufacturers are working to enhance their devices, our commitment lies in making them smarter in an unparalleled manner to improve the efficiency and workflow of ultrasound imaging."

United Imaging Intelligence Unveiled Next-Generation Radiology Solutions at ECR 2024

Retrieved on: 
Friday, March 1, 2024

VIENNA, March 1, 2024 /PRNewswire/ -- At the European Congress of Radiology (ECR) 2024 in Vienna, United Imaging Intelligence (UII), a subsidiary of United Imaging Group, proudly presented its latest advances in medical AI technology.

Key Points: 
  • VIENNA, March 1, 2024 /PRNewswire/ -- At the European Congress of Radiology (ECR) 2024 in Vienna, United Imaging Intelligence (UII), a subsidiary of United Imaging Group, proudly presented its latest advances in medical AI technology.
  • Renowned for its AI-driven healthcare applications, UII's presentation at ECR 2024 marked a significant leap toward "Next Generation Radiology," showcasing intelligent healthcare solutions in alignment with the congress's forward-looking theme.
  • Amidst the rapid transformation of the medical technology landscape driven by foundation models, UII adopts these crucial frameworks to enhance 'Next Generation Radiology'.
  • At ECR 2024, UII introduced uAI SAT, an innovative AI-driven annotation tool hosted on its biomedical research platform.

Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

Retrieved on: 
Wednesday, February 28, 2024

SEOUL, South Korea, Feb. 28, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of seven studies at the European Congress of Radiology (ECR) 2024, to be held in Vienna, Austria, from February 28 to March 3. Four will be presented through oral presentations and three as E-posters.

Key Points: 
  • Four out of seven AI products, including Lunit INSIGHT CXR, showed superior performance compared to human readers.
  • Lunit invites booth visitors at ECR 2024 to explore detailed information on the project and discuss potential future collaborations.
  • "We are proud to present our latest research findings at this year's ECR, demonstrating the robust performance and versatility of our Lunit INSIGHT suite in various clinical settings and scenarios.
  • Join Lunit at booth AI-15 in the EXPO X1 hall to witness how the Lunit INSIGHT suite is shaping the future of radiology across the globe.